STING1 and neoplasm: We did not observe diminished expression of other immune sensors MAVS and MyD88 or downstream components of these immune pathways TBK1 and IRF3; suggesting that targeting of STING-specific immune responses may be an important strategy to facilitate tumor progression in HPV+ HNSCCs.